Last Updated:
Searching
Create account to add to watchlist!

dMY Technology Group, Inc. VI - DMYS

  • Commons

    $9.83

    -0.91%

    DMYS Vol: 548.1K

  • Warrants

    $1.38

    -6.76%

    DMYS+ Vol: 331.1K

  • Units

    $10.53

    -0.66%

    DMYS= Vol: 393.5K

Average: 0
Rating Count: 0
You Rated: Not rated

Please log in to rate.

SPAC Stats

Market Cap: 0.0
Average Volume: 456.4K
52W Range: $9.76 - $10.45
Weekly %: -1.80%
Monthly %: +0.00%
Inst Owners: nan

Info

Target: Searching
Days Since IPO: 65
Unit composition:
Each unit has an offering price of $10.00 and consists of one share of Class A common stock and one-fifth of one redeemable warrant
Trust Size: 25000000.0M

🕵Stocktwit Mentions

roje2021 posted at 2021-12-04T02:42:18Z

$DMYS Need to avg. down. Thought his would hold up at least in the 9.90s

tmarkz87 posted at 2021-12-04T02:33:17Z

$DMYS Something in the Metaverse would be 👌

S_F_H posted at 2021-12-03T21:06:14Z

$DMYS All cash that wasn’t already parked somewhere else was parked in warrants today. IMO this is about as low as warrants will get. We will see. Never thought I would have an average of $1.31.

Mexu posted at 2021-12-03T18:26:53Z

$DMYS somebody has mixed up this with $DMYQ

kylo_invests posted at 2021-12-03T17:47:02Z

$DMYS would’ve been cooler to get in under $9.80 🙆🏻‍♂️

kylo_invests posted at 2021-12-03T14:44:11Z

$DMYS In under $10.

Mbr33 posted at 2021-12-01T19:03:05Z

$DMYQ same price as $DMYS

shortvolumes posted at 2021-11-28T08:41:32Z

2021-11-26 Short sale volume (not short interest) for $DMYS is 66%. http://shortvolumes.com/?t=DMYS via @shortvolumes

Grade1View posted at 2021-11-27T01:06:22Z

$DMYS Red market gives opportunities for those looking…. I’m buying under $10 hand over fist. Also…. would love to see warrants keep bleeding 🩸 🩸 🔥

Tier1credit posted at 2021-11-26T21:25:07Z

$DMYS we’re in here 4800 shares $10.02 😬

DAlighieri posted at 2021-11-26T17:26:22Z

$DMYS nice sale on Warrants !

ProTraderColin posted at 2021-11-26T17:24:33Z

$DMYS bought a lot at 10.02. Almost zero downside risk.

SpacThatAsk posted at 2021-11-26T17:13:42Z

$DMYS warrants would drop when i split lol sob

knulp posted at 2021-11-26T16:47:32Z

$DMYS What is the difference between DMYS & DMYS-UN? Thanks in advance.

SpacThatAsk posted at 2021-11-24T16:39:23Z

$DMYS Volume is decent i hope we get options sooner than later

HankHank posted at 2021-11-24T14:53:10Z

$DMYS 11 sooner than later 🔥

nowaydude posted at 2021-11-24T14:15:01Z

$DMYS

Todorecto posted at 2021-11-24T07:16:46Z

$DMYS 👁️👁️

HankHank posted at 2021-11-23T18:03:08Z

$DMYS $IONQ $DMYQ $RSI is next!! https://seekingalpha.com/article/4471136-3-best-forever-spacs-for-2022-ionq-dmyq-and-dmys

HankHank posted at 2021-11-23T16:44:06Z

$DMYS $IONQ $DMYQ

HankHank posted at 2021-11-23T16:41:57Z

$DMYS 🔥and $IPOF best safe plays now

HankHank posted at 2021-11-23T15:44:58Z

$DMYS all in ”in Park” here in Dmys. Too volatile markets now, $IONQ $DMYQ

TheForceAwakens posted at 2021-11-23T07:40:30Z

$DMYS what company?

RorschachTest posted at 2021-11-23T06:02:27Z

$DMYS Feeling good, but really wanted to add warrants. If the market flips and the warrants take a hit ill make a move. For now adding doesn't make sense. $2 pre da warrants are way too risky for me.

SpacThatAsk posted at 2021-11-23T01:42:05Z

$DMYS What a split price. congrats to early unit holders

stocktwitzbull posted at 2021-11-22T23:28:29Z

$DMYS too expensive for me — love dmy but — I’m waiting for a better entry

miket3 posted at 2021-11-22T21:33:44Z

$DMYS Igac with warrants under a buck has just a good a chance as dmys at 1.70 . Come join the party that will be

Grade1View posted at 2021-11-22T21:17:48Z

$DMYS I’ve got units from October, added some commons for under 10 today and picked up a starter warrant position for 1.71. I hate paying that for warrants but I want exposure. Putting it here on the record. I’m hoping they drop and I can get a real size position.

roje2021 posted at 2021-11-22T20:01:32Z

$DMYS time to start accumulating. Would prefer it to drop to the 9.80s before really diving in though. May not happen given their track record.

GangHang posted at 2021-11-22T15:19:52Z

$DMYS what is with DMY V? Doesn’t exist?

Management

Officers, Directors and Director Nominees.” Our officers and directors presently have, and any of them in the future may have additional, fiduciary or contractual obligations to other entities and, accordingly, may have conflicts of interest in determining to which entity a particular business opportunity should be presented. Following the completion of this offering and until we consummate our initial business combination, we intend to engage in the business of identifying and combining with one or more businesses. Each of our officers and directors presently has, and any of them in the future may have, additional fiduciary or contractual obligations to other entities pursuant to which such officer or director is or will be required to present a business combination opportunity to such entity, including dMY IV and AdMY, which are sponsored by affiliates of our sponsor. Accordingly, they may have conflicts of interest in determining to which entity a particular business opportunity should be presented. These conflicts may not be resolved in our favor and a potential target business may be presented to another entity prior to its presentation to us. Our amended and restated certificate of 56 Table of Contents incorporation will provide that we renounce our interest in any corporate opportunity offered to any director or officer unless such opportunity is expressly offered to such person solely in his or her capacity as a director or officer of the company and such opportunity is one we are legally and contractually permitted to undertake and would otherwise be reasonable for us to pursue, and to the extent the director or officer is permitted to refer that opportunity to us without violating another legal obligation. In addition, our sponsor and our officers and directors may sponsor or form other special purpose acquisition companies similar to ours or may pursue other business or investment ventures during the period in which we are seeking an initial business combination. Each of our officers and directors presently has, and any of them in the future may have additional, fiduciary or contractual obligations to another entity pursuant to which such officer or director is or will be required to present a business combination opportunity to such entity, including dMY IV and AdMY, which are sponsored by affiliates of our sponsor. Our amended and restated certificate of incorporation will provide that we renounce our interest in any corporate opportunity offered to any director or officer unless such opportunity is expressly offered to such person solely in his or her capacity as a director or officer of the company and such opportunity is one we are legally and contractually permitted to undertake and would otherwise be reasonable for us to pursue, and to the extent the director or officer is permitted to refer that opportunity to us without violating another legal obligation. Accordingly, if any of our officers or directors becomes aware of a business combination opportunity which is suitable for an entity to which he or she has then current fiduciary or contractual obligations (including dMY IV or AdMY), he or she will honor his or her fiduciary or contractual obligations to present such business combination opportunity to such other entity. We do not believe, however, that the fiduciary duties or contractual obligations of our officers or directors will materially affect our ability to complete our initial business combination. In addition, our sponsor and our officers and directors may sponsor or form other special purpose acquisition companies similar to ours or may pursue other business or investment ventures during the period in which we are seeking an initial business combination. Any such companies, businesses or investments may present additional conflicts of interest in pursuing an initial business combination. In particular, affiliates of our sponsor are currently sponsoring other blank check companies: dMY III, dMY IV and AdMY. On March 8, 2021, dMY III announced that it had entered into a definitive agreement to merger with IonQ, Inc., a Delaware corporation and a leading pure-play hardware and software company in the quantum computing space. The transaction is subject to approval of dMY III’s stockholders and other customary closing conditions and no assurances can be given as to whether or when this transaction will close. This prospectus does not constitute a solicitation of proxies in connection with the merger. In the event that dMY III’s stockholders do not approve the transaction or the transaction is otherwise unable to close, dMY III may continue to pursue initial business combination targets until December 7, 2021 (absent an extension in accordance with its charter). Upon completion of its initial public offering, dMY IV, which focuses on business combinations in the broader consumer technology ecosystem that are either consumer-facing or support the infrastructure of consumer applications and may look for an acquisition target in any location, has a window in which it may complete its initial business combination that overlaps the corresponding window we have. Upon completion of its initial public offering, AdMY, which focuses on business combinations in the broader communications and cloud infrastructure ecosystem, which seeks to leverage the power of 5G wireless communications as well as distributed edge and cloud computing and may look for an acquisition target in any location, has a window in which it may complete its initial business combination that overlaps with the corresponding window we have. Further, Mr. You, our Co-Chairman, serves as the Chairman of dMY III and for dMY IV and Mr. de Masi, our Chief Executive Officer, serves as the Chief Executive Officer for dMY III and for dMY IV. Mr. You and Mr. de Masi are also acting as Co-Chairmen for AdMY. Any such companies, including dMY III, dMY IV and AdMY, may present additional conflicts of interest in pursuing an acquisition target. However, we do not believe that any such potential conflicts would materially affect our ability to complete our initial business combination because our management team has significant experience in identifying and executing multiple acquisition opportunities simultaneously, and as we believe there are a number of potential opportunities within the industries and geographies of our primary focus. 57 Table of Contents For a complete discussion of our executive officers’ and directors’ business affiliations and the potential conflicts of interest that you should be aware of, please see “Management—Officers, Directors and Director Nominees,” “Management—Conflicts of Interest” and “Certain Relationships and Related Party Transactions.” Our executive officers, directors, security holders and their respective affiliates may have competitive pecuniary interests that conflict with our interests. We have not adopted a policy that expressly prohibits our directors, executive officers, security holders or affiliates from having a direct or indirect pecuniary or financial interest in any investment to be acquired or disposed of by us or in any transaction to which we are a party or have an interest. In fact, we may enter into a business combination with a target business that is affiliated with our sponsor, our directors or executive officers, although we do not intend to do so. Nor do we have a policy that expressly prohibits any such persons from engaging for their own account in business activities of the types conducted by us. Accordingly, such persons or entities may have a conflict between their interests and ours. The personal and financial interests of our directors and officers may influence their motivation in timely identifying and selecting a target business and completing a business combination. Consequently, our directors’ and officers’ discretion in identifying and selecting a suitable target business may result in a conflict of interest when determining whether the terms, conditions and timing of a particular business combination are appropriate and in our stockholders’ best interest. If this were the case, it would be a breach of their fiduciary duties to us as a matter of Delaware law and we or our stockholders might have a claim against such individuals for infringing on our stockholders’ rights. However, we might not ultimately be successful in any claim we may make against them for such reason. We may engage in a business combination with one or more target businesses that have relationships with entities that may be affiliated with our sponsor, executive officers, directors or existing holders which may raise potential conflicts of interest. In light of the involvement of our sponsor, executive officers and directors with other entities, we may decide to acquire one or more businesses affiliated with our sponsor, executive officers, directors or existing holders. Our directors also serve as officers and board members for other entities, including, without limitation, those described under “Management—Conflicts of Interest.” Such entities may compete with us for business combination opportunities. Our sponsor, officers and directors are not currently aware of any specific opportunities for us to complete our initial business combination with any entities with which they are affiliated, and there have been no substantive discussions concerning a business combination with any such entity or entities. Although we will not be specifically focusing on, or targeting, any transaction with any affiliated entities, we would pursue such a transaction if we determined that such affiliated entity met our criteria for a business combination as set forth in “Proposed Business—Effecting our initial business combination—Selection of a target business and structuring of our initial business combination” and such transaction was approved by a majority of our independent and disinterested directors. Despite our agreement to obtain an opinion from an independent investment banking firm which is a member of FINRA or a valuation or appraisal firm regarding the fairness to our company from a financial point of view of a business combination with one or more domestic or international businesses affiliated with our sponsor, executive officers, directors or existing holders, potential conflicts of interest still may exist and, as a result, the terms of the business combination may not be as advantageous to our public stockholders as they would be absent any conflicts of interest. 58 Table of Contents We may engage one or more of our underwriters or one of their respective affiliates to provide additional services to us after this offering, which may include acting as financial advisor in connection with an initial business combination or as placement agent in connection with a related financing transaction. Our underwriters are entitled to receive deferred commissions that will be released from the trust only on a completion of an initial business combination. These financial incentives may cause them to have potential conflicts of interest in rendering any such additional services to us after this offering, including, for example, in connection with the sourcing and consummation of an initial business combination. We may engage one or more of our underwriters or one of their respective affiliates to provide additional services to us after this offering, including, for example, identifying potential targets, providing financial advisory services, acting as a placement agent in a private offering or arranging debt financing. We may pay such underwriter or its affiliate fair and reasonable fees or other compensation that would be determined at that time in an arm’s length negotiation; provided that no agreement will be entered into with any of the underwriters or their respective affiliates and no fees or other compensation for such services will be paid to any of the underwriters or their respective affiliates prior to the date that is 60 days from the date of this prospectus, unless such payment would not be deemed underwriters’ compensation in connection with this offering. The underwriters are also entitled to receive deferred commissions that are conditioned on the completion of an initial business combination. The underwriters’ or their respective affiliates’ financial interests tied to the consummation of a business combination transaction may give rise to potential conflicts of interest in providing any such additional services to us, including potential conflicts of interest in connection with the sourcing and consummation of an initial business combination. Since our sponsor, executive officers and directors will lose their entire investment in us if our initial business combination is not completed (other than with respect to public shares they may acquire during or after this offering), a conflict of interest may arise in determining whether a particular business combination target is appropriate for our initial business combination. On April 16, 2021, our sponsor subscribed for an aggregate 7,187,500 founder shares for a total subscription price of $25,000, or approximately $0.003 per share. Such shares are fully paid, and the cash amount of the subscription price therefor was received on April 27, 2021. A small group of investors, including of our independent directors, contributed to our sponsor of the risk capital for an interest in our sponsor corresponding to approximately of our sponsor’s founder shares. Mr. You, the manager of our sponsor, has voting and investment discretion with respect to the common stock held by the sponsor. Our sponsor intends to transfer 25,000 founder shares to each of Darla Anderson, Becky Ann Hughes and Francesca Luthi, our director nominees, upon the completion of our initial business combination, resulting in our sponsor holding at that time 7,112,500 founder shares. Prior to the initial investment in the company of $25,000 by the sponsor, the company had no assets, tangible or intangible. The purchase price of the founder shares was determined by dividing the amount of cash contributed to the company by the number of founder shares issued. The number of founder shares outstanding was determined based on the expectation that the total size of this offering would be a maximum of 28,750,000 units if the underwriters’ over-allotment option is exercised in full, and therefore that such founder shares would represent 20% of the outstanding shares after this offering. Up to 937,500 of the founder shares will be forfeited depending on the extent to which the underwriters’ over-allotment is exercised. The founder shares will be worthless if we do not complete an initial business combination. In addition, our sponsor has committed to purchase an aggregate of 4,666,667 private placement warrants (or 5,166,667 warrants if the underwriters’ over-allotment option is exercised in full), each exercisable for one share of Class A common stock at $11.50 per share, for an aggregate purchase price of $7,000,000 (or $7,750,000 if the underwriters’ over-allotment option is exercised in full), or $1.50 per warrant, that will also be worthless if we do not complete our initial business combination. The personal and financial interests of our executive officers and directors may influence their motivation in identifying and selecting a target business combination, completing an initial business combination and influencing the operation of the business following the initial business combination. This risk may become more acute as the 24-month anniversary of the closing of this offering nears, which is the deadline for our completion of an initial business combination. 59 Table of Contents Our management may not maintain control of a target business after our initial business combination. We cannot provide assurance that, upon loss of control of a target business, new management will possess the skills, qualifications or abilities necessary to profitably operate such business. We may structure our initial business combination so that the post-transaction company in which our public stockholders own shares will own less than 100% of the equity interests or assets of a target business, but we will only complete such business combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for us not to be required to register as an investment company under the Investment Company Act. We will not consider any transaction that does not meet such criteria. Even if the post-transaction company owns 50% or more of the voting securities of the target, our stockholders prior to the business combination may collectively own a minority interest in the post business combination company, depending on valuations ascribed to the target and us in the business combination. For example, we could pursue a transaction in which we issue a substantial number of new shares of Class A common stock in exchange for all of the outstanding capital stock of a target. In this case, we would acquire a 100% interest in the target. However, as a result of the issuance of a substantial number of new shares of Class A common stock, our stockholders immediately prior to such transaction could own less than a majority of our outstanding Class A common stock subsequent to such transaction. In addition, other minority stockholders may subsequently combine their holdings resulting in a single person or group obtaining a larger share of the company’s shares than we initially acquired. Accordingly, this may make it more likely that our management will not maintain control of the target business. Risks relating to our Securities Our initial stockholders paid an aggregate of $25,000 to purchase 7,187,500 founder shares, or approximately $0.003 per founder share and, accordingly, you will experience immediate and substantial dilution from the purchase of our shares of Class A common stock. The difference between the public offering price per share (allocating all of the unit purchase price to the share of Class A common stock and none to the warrant included in the unit) and the pro forma net tangible book value per share of our Class A common stock after this offering constitutes the dilution to you and the other investors in this offering. Our initial stockholders acquired the founder shares at a nominal price, significantly contributing to this dilution. Upon closing of this offering, and assuming no value is ascribed to the warrants included in the units, you and the other public stockholders will incur an immediate and substantial dilution of approximately 94.1% or $9.41 per share, assuming no exercise of the underwriters’ over-allotment option, the difference between the pro forma net tangible book value per share after this offering of $0.59 and the initial offering price of $10.00 per unit. This dilution would increase to the extent that the anti-dilution provisions of the founder shares result in the issuance of shares of Class A common stock on a greater than one-to-one basis upon conversion of the founder shares at the time of our initial business combination and would become exacerbated to the extent that public stockholders seek redemptions from the trust for their public shares. In addition, because of the anti-dilution protection in the founder shares, any equity or equity-linked securities issued in connection with our initial business combination would be disproportionately dilutive to our Class A common stock. The nominal purchase price paid by our sponsor for the founder shares may result in significant dilution to the implied value of your public shares upon the consummation of our initial business combi

Holder Stats

1 0
% of Shares Held by All Insider NaN
% of Shares Held by Institutions NaN
% of Float Held by Institutions NaN
Number of Institutions Holding Shares NaN

SEC Filings

Form Type Form Description Filing Date Document Link
8-K 8-K 2021-11-19 https://www.sec.gov/Archives/edgar/data/1858327/000119312521334574/d263430d8k.htm
10-Q 10-Q 2021-11-15 https://www.sec.gov/Archives/edgar/data/1858327/000119312521330012/d226484d10q.htm
SC 13G SCHEDULE 13G 2021-10-15 https://www.sec.gov/Archives/edgar/data/1858327/000095014221003182/eh210191272_13g-dmys.htm
8-K FORM 8-K 2021-10-12 https://www.sec.gov/Archives/edgar/data/1858327/000119312521296925/d189013d8k.htm
SC 13G 2021-10-08 https://www.sec.gov/Archives/edgar/data/1858327/000131924421000253/DMYS_SC13G.htm
8-K 8-K 2021-10-05 https://www.sec.gov/Archives/edgar/data/1858327/000119312521292261/d215596d8k.htm
4 FORM 4 SUBMISSION 2021-10-04 https://www.sec.gov/Archives/edgar/data/1858327/000089924321038860/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-10-04 https://www.sec.gov/Archives/edgar/data/1858327/000089924321038859/xslF345X03/doc4.xml
424B4 424B4 2021-10-04 https://www.sec.gov/Archives/edgar/data/1858327/000119312521291122/d346003d424b4.htm
8-K 8-K 2021-10-01 https://www.sec.gov/Archives/edgar/data/1858327/000119312521288878/d206052d8k.htm
425 8-K 2021-10-01 https://www.sec.gov/Archives/edgar/data/1858327/000119312521288879/d206052d8k.htm
EFFECT 2021-09-30 https://www.sec.gov/Archives/edgar/data/1858327/999999999521003711/xslEFFECTX01/primary_doc.xml
S-1MEF S-1MEF 2021-09-30 https://www.sec.gov/Archives/edgar/data/1858327/000119312521288391/d239348ds1mef.htm
3 FORM 3 SUBMISSION 2021-09-30 https://www.sec.gov/Archives/edgar/data/1858327/000089924321038409/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-09-30 https://www.sec.gov/Archives/edgar/data/1858327/000089924321038407/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-09-30 https://www.sec.gov/Archives/edgar/data/1858327/000089924321038405/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-09-30 https://www.sec.gov/Archives/edgar/data/1858327/000089924321038404/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-09-30 https://www.sec.gov/Archives/edgar/data/1858327/000089924321038402/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-09-30 https://www.sec.gov/Archives/edgar/data/1858327/000089924321038400/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-09-30 https://www.sec.gov/Archives/edgar/data/1858327/000089924321038398/xslF345X02/doc3.xml
CERT NYSE CERTIFICATION 2021-09-30 https://www.sec.gov/Archives/edgar/data/1858327/000087666121001426/DMYS093021.pdf
8-A12B 8-A12B 2021-09-30 https://www.sec.gov/Archives/edgar/data/1858327/000119312521288075/d225379d8a12b.htm
CORRESP 2021-09-28 https://www.sec.gov/Archives/edgar/data/1858327/000119312521285291/filename1.htm
CORRESP 2021-09-28 https://www.sec.gov/Archives/edgar/data/1858327/000119312521285286/filename1.htm
S-1/A S-1/A 2021-09-27 https://www.sec.gov/Archives/edgar/data/1858327/000119312521284147/d346003ds1a.htm
S-1/A S-1/A 2021-08-16 https://www.sec.gov/Archives/edgar/data/1858327/000119312521246412/d346003ds1a.htm
UPLOAD 2021-07-02 https://www.sec.gov/Archives/edgar/data/1858327/000000000021008242/filename1.pdf
S-1/A S-1/A 2021-06-28 https://www.sec.gov/Archives/edgar/data/1858327/000119312521201834/d346003ds1a.htm
S-1 S-1 2021-06-25 https://www.sec.gov/Archives/edgar/data/1858327/000119312521199380/d346003ds1.htm